Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

US NIH to back the unconventional

This article was originally published in Scrip

The US National Institutes of Healthare providing $42.2 million for 38 research projects that it considers to be "exceptionally innovative", and represent unconventional approaches. The grants are the first to be made under the EUREKA (Exceptional, Unconventional, Research Enabling Knowledge Acceleration) programme and include the reprogramming of adult cells (fibroblasts) to resemble embryonic stem cells and an RNA-based strategy to get substances into the brain without an injection. The first is being conducted by Dr Tanja Dominko at Worcester Polytechnic Institute, Massachusetts, and the second by Dr Beverly Davidson of the University of Iowa, Iowa City.

Latest Headlines
See All
UsernamePublicRestriction

Register

SC000138

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel